From November 14 to 17, one of the key annual events in the field of X-ray endovascular diagnostics and treatment took place — XXVI Moscow International Congress on X-ray Endovascular Surgery (MRC 2024). For four days, scientific and educational programs were held in parallel in several halls, prepared by working groups under the leadership of the president of the congress, academician of the Russian Academy of Sciences Bagrat Gegamovich Alekyan. The congress was held in Moscow at the Lotte Hotel Moscow.
Key point: At MRC 2024 Raymed Group joined the Stentex discussion on domestic manufacturers and showed its product portfolio; Tushar Borse presented the RK GROUP production site in Grozny.
Raymed Group organized the satellite symposium «Introduction of European iVascular technologies into the production of Russian coronary stents». Specialists from India, Serbia and Russia took part in the discussion.
In addition, the company joined the discussion organized by Stentex on the topic «The place of domestic manufacturers in the work of RHMDL branches in Russia». The event was attended by representatives of the Ministry of Health of the Russian Federation, the Ministry of Industry and Trade of the Russian Federation, Roszdravnadzor, as well as Russian manufacturers of medical devices: LLC "RK Group", LLC "Stentex", ZAO NPP "Meding" and JSC "R-Vascular".
RK Group Deputy Director for Production Tushar Borse made a report on the production site of RK GROUP in Grozny.
As part of the congress, the company also presented its product portfolio at the exhibition.
